| B-cell depleting therapies may affect susceptibility to acute respiratory illness among patients with multiple sclerosis during the early COVID-19 epidemic in Iran ARA Farinaz Safavia,1, Bardia Nourbakhshb,1 Multiple Sclerosis and Related Disorders, 2020 | 144 | 2020 |
| Autoimmune diseases associated with neuromyelitis optica spectrum disorders: a literature review S Shahmohammadi, R Doosti, A Shahmohammadi, ... Multiple sclerosis and related disorders 27, 350-363, 2019 | 141 | 2019 |
| Coenzyme Q10 supplementation ameliorates inflammatory markers in patients with multiple sclerosis: a double blind, placebo, controlled randomized clinical trial M Sanoobar, S Eghtesadi, A Azimi, M Khalili, B Khodadadi, S Jazayeri, ... Nutritional neuroscience 18 (4), 169-176, 2015 | 135 | 2015 |
| Coenzyme Q10 as a treatment for fatigue and depression in multiple sclerosis patients: A double blind randomized clinical trial M Sanoobar, P Dehghan, M Khalili, A Azimi, F Seifar Nutritional neuroscience 19 (3), 138-143, 2016 | 132 | 2016 |
| Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with relapsing–remitting multiple sclerosis M Sanoobar, S Eghtesadi, A Azimi, M Khalili, S Jazayeri, M Reza Gohari International Journal of Neuroscience 123 (11), 776-782, 2013 | 115 | 2013 |
| Evaluation of the rate of COVID-19 infection, hospitalization and death among Iranian patients with multiple sclerosis MA Sahraian, A Azimi, S Navardi, S Ala, AN Moghadasi Multiple sclerosis and related disorders 46, 102472, 2020 | 92 | 2020 |
| Validity and reliability of a Persian translation of the Minimal Assessment of Cognitive Function in Multiple Sclerosis (MACFIMS) A Eshaghi, S Riyahi-Alam, T Roostaei, G Haeri, A Aghsaei, MR Aidi, ... The Clinical Neuropsychologist 26 (6), 975-984, 2012 | 81 | 2012 |
| Does lipoic acid consumption affect the cytokine profile in multiple sclerosis patients: a double-blind, placebo-controlled, randomized clinical trial M Khalili, A Azimi, V Izadi, S Eghtesadi, A Mirshafiey, MA Sahraian, ... Neuroimmunomodulation 21 (6), 291-296, 2014 | 78 | 2014 |
| Fatigue in multiple sclerosis: relationship with disease duration, physical disability, disease pattern, age and sex M Ghajarzadeh, R Jalilian, G Eskandari, MA Sahraian, A Azimi, ... Acta Neurologica Belgica 113, 411-414, 2013 | 78 | 2013 |
| Validity and reliability of Persian version of Modified Fatigue Impact Scale (MFIS) questionnaire in Iranian patients with multiple sclerosis M Ghajarzadeh, R Jalilian, G Eskandari, M Ali Sahraian, A Reza Azimi Disability and rehabilitation 35 (18), 1509-1512, 2013 | 74 | 2013 |
| Androgen-induced cerebral venous sinus thrombosis in a young body builder: case report MA Sahraian, M Mottamedi, AR Azimi, B Moghimi BMC neurology 4, 1-6, 2004 | 73 | 2004 |
| α-Lipoic acid, functional fatty acid, as a novel therapeutic alternative for central nervous system diseases: A review F Seifar, M Khalili, H Khaledyan, S Amiri Moghadam, A Izadi, A Azimi, ... Nutritional neuroscience 22 (5), 306-316, 2019 | 62 | 2019 |
| Effect of lipoic acid consumption on oxidative stress among multiple sclerosis patients: a randomized controlled clinical trial M Khalili, S Eghtesadi, A Mirshafiey, G Eskandari, M Sanoobar, ... Nutritional neuroscience 17 (1), 16-20, 2014 | 61 | 2014 |
| Anxiety in patients with multiple sclerosis: association with disability, depression, disease type and sex F Askari, M Ghajarzadeh, M Mohammadifar, A Azimi, MA Sahraian, ... Acta Medica Iranica, 889-892, 2014 | 59 | 2014 |
| Neuromyelitis optica spectrum disorders in Iran S Eskandarieh, S Nedjat, AR Azimi, AN Moghadasi, MA Sahraian Multiple sclerosis and related disorders 18, 209-212, 2017 | 53 | 2017 |
| Vitamin D supplementation up-regulates IL-6 and IL-17A gene expression in multiple sclerosis patients BN Gargari, M Behmanesh, ZS Farsani, MP Kakhki, AR Azimi International immunopharmacology 28 (1), 414-419, 2015 | 52 | 2015 |
| Classification algorithms with multi-modal data fusion could accurately distinguish neuromyelitis optica from multiple sclerosis A Eshaghi, S Riyahi-Alam, R Saeedi, T Roostaei, A Nazeri, A Aghsaei, ... NeuroImage: Clinical 7, 306-314, 2015 | 48 | 2015 |
| Vitamin D and multiple sclerosis: a critical review and recommendations on treatment A Faridar, G Eskandari, MA Sahraian, A Minagar, A Azimi Acta Neurologica Belgica 112, 327-333, 2012 | 44 | 2012 |
| Association of nod‐like receptor protein‐3 single nucleotide gene polymorphisms and expression with the susceptibility to relapsing–remitting multiple sclerosis D Imani, A Azimi, Z Salehi, N Rezaei, R Emamnejad, M Sadr, M Izad International journal of immunogenetics 45 (6), 329-336, 2018 | 41 | 2018 |
| Environmental risk factors in neuromyelitis optica spectrum disorder: a case–control study S Eskandarieh, S Nedjat, I Abdollahpour, AR Azimi, AN Moghadasi, ... Acta Neurologica Belgica 118, 277-287, 2018 | 38 | 2018 |
Mahsa GhajarzadehJohns Hopkins University, MS research centerVerified email at jhmi.edu
